Phase II Trial of Cetuximab (C225) in Combination with Monthly Carboplatin (Cb) and Weekly Paclitaxel (Pac) in Patients with Advanced NSCLC: Promising Early Results.

Details

Language :

English

ISSN :

15560864

Volume :

2

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

115803984

Full Text :

https://doi.org/10.1097/01.JTO.0000283410.30744.4f